Medicare’s Skilled Nursing Facility Value-Based Purchasing Program Fails to Lower Hospital Readmissions
New Incentive Structures and Metrics May Improve Program Performance
In Their Own Words
FDA Boosted Florida’s Drug Import Plan From Canada, But the Canadians and Big Pharma Probably Won’t Play Along
There Are Better Ways to Achieve These Goals, an LDI Expert Writes
Print:
The following excerpt is from an op-ed that first appeared in MedPage Today on February 24th, 2024.
If you head to the Florida beaches for spring break, you will notice that the Canadian Maple Leaf is often present among the flags outside hotels and tourist apartments. The benefit to Florida from the annual migration of snowbirds from the North has long been evident, but now something more unusual may be coming from Canada.
On January 5, the FDA approved (with conditions) a request from Gov. Ron DeSantis (R.-Fla.) to import prescription drugs from Canada, making Florida the first state ever given authority to import prescription drugs from another country. The Florida Medicaid program is likely hard at work now devising a plan to source large quantities of drugs from Canada, where unit prices are often small fractions of the U.S. list price.
This unprecedented plan begs many questions: Why is it happening in the first place? Who will benefit from or be harmed by this practice? Could it spread to other U.S. states?
Read the entire op-ed here.
Author
Mark V. Pauly, PhD
Bendheim Professor Emeritus, Health Care Management, Wharton School; Professor, Economics, School of Arts and Sciences
More on Health Care Access & Coverage
Research Memo: Projected Mortality Impacts of the Budget Reconciliation Bill
Response to Request for Technical Assistance
Two Looming Crises Threaten to Collapse U.S. Long-Term Care
Immigration Crackdown and Medicaid Cuts Put Millions at Risk
The Public Chafed the Last Time the GOP Tried to Cut Medicaid
Will This Time be Different? Past Health Bills Hold Clues
Research Memo: Loss of Subsidized Drug Coverage and Mortality Following Medicaid Disenrollment: Translating our Findings and Implications for Medicaid Policy
Supplement to Response to Request for Technical Assistance
Medicare’s New Drug Spending Cap Will Likely Help Few Seniors
Many With High Drug Costs Have Supplemental Coverage and Won’t Reach the $2,000 Out-of-Pocket Cap, a New LDI Study Finds